Related Experiment Videos
The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide
Barbara Bp Yawn1, Byron Thomashaw2, David M Mannino3
1Department of Family and Community Health, University of Minnesota School of Medicine, Minneapolis.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|August 30, 2017
Summary
The COPD Foundation Pocket Consultant Guide (PCG) offers updated clinical guidance for diagnosing and treating chronic obstructive pulmonary disease (COPD). This tool aids primary care clinicians in daily practice with the latest recommendations for stepped care and dual bronchodilator therapy.
Area of Science:
- Pulmonary Medicine
- Clinical Decision Support
Background:
- The COPD Foundation Pocket Consultant Guide (PCG) was initially developed in 2007.
- It has evolved to include a mobile app for point-of-service clinical decision-making.
- The PCG assists clinicians in diagnosing and managing chronic obstructive pulmonary disease (COPD).
Purpose of the Study:
- To provide an updated practice tool for clinicians managing COPD.
- To incorporate the latest diagnostic and treatment recommendations into the PCG.
- To support clinical decision-making regarding stepped care, dual bronchodilator therapy, and inhaled corticosteroid use.
Main Methods:
- The PCG was updated in November 2016.
- The update includes a flow diagram for stepped care management.
- It incorporates new recommendations for diagnosis, assessment, and treatment of COPD.
- Consideration of asthma COPD overlap syndrome (ACOS) and inhaled corticosteroid (ICS) use is included.
Main Results:
- The updated PCG features a stepped care flow diagram.
- It emphasizes dual bronchodilator therapy and ACOS assessment.
- The guide addresses the controversy surrounding ICS initiation.
- Spirometry is recommended for high-risk individuals.
- Assessment of symptoms, exacerbation risk, and comorbidities is highlighted before therapy selection.
Conclusions:
- The updated PCG facilitates COPD management in daily clinical practice.
- It provides clinicians with current evidence-based guidance.
- The tool supports informed decisions on non-pharmacological and pharmacological therapies for COPD.